Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCI plus Guanxinning Tablets for Acute Coronary Syndrome
ChiCTR2100054242Phase 4Recruiting
- Sponsor
- Hangzhou Red Cross Hospital
- Start
- Jun 2021
- Countries
- 1
01
Overview
Phase 4 trial of Guanxinning in acute coronary syndrome (ACS) (2 arms), sponsored by Hangzhou Red Cross Hospital. Primary endpoints: Times of angina pectoris and Angina pectoris duration. Started Jun 2021; status: recruiting.
02
Drugs
Guanxinning
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR2100054242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054242.